about
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.Modulation of GABAA receptors in the treatment of epilepsy.Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives.Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions.A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy.Neurobiological Correlates of Alpha-Tocopherol Antiepileptogenic Effects and MicroRNA Expression Modulation in a Rat Model of Kainate-Induced Seizures.A novel GABAergic dysfunction in human Dravet syndrome
P50
Q36710671-AF653E01-02E3-4274-893F-A6CE7A10B8D9Q38643908-4BAA843B-E053-471E-BF09-7E930C991CD5Q38809433-C1BF0D08-7855-4EB0-8910-7BDA117EB918Q39593379-71C384BF-C0F4-4484-B44B-556DEFA385D3Q52604399-2E9E0346-4616-4993-98A7-2383C55FFB04Q52691067-AC57D6EE-C400-45EC-9B11-6E52C960652FQ57280447-A90941D9-7B00-4CC6-AD62-18933DA344F7
P50
description
researcher ORCID ID = 0000-0002-6554-5496
@en
wetenschapper
@nl
name
Gabriele Ruffolo
@ast
Gabriele Ruffolo
@en
Gabriele Ruffolo
@es
Gabriele Ruffolo
@nl
type
label
Gabriele Ruffolo
@ast
Gabriele Ruffolo
@en
Gabriele Ruffolo
@es
Gabriele Ruffolo
@nl
prefLabel
Gabriele Ruffolo
@ast
Gabriele Ruffolo
@en
Gabriele Ruffolo
@es
Gabriele Ruffolo
@nl
P1153
56720340600
P31
P496
0000-0002-6554-5496